Information  X 
Enter a valid email address

Mirriad Advertising (MIRI)

  Print      Mail a friend

Wednesday 31 July, 2019

Mirriad Advertising

GM Statement

RNS Number : 3914H
Mirriad Advertising PLC
31 July 2019
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Mirriad Advertising plc

Result of GENERAL MEETING

31 July 2019

 

Mirriad Advertising plc

 


Result of General Meeting



Mirriad Advertising plc ("Mirriad" or the "Company"), the established computer vision and AI platform company, is pleased to announce that at the General Meeting held earlier today, all resolutions put to shareholders were duly passed.

Details of the proxy votes received in relation to each of the Resolutions are as follows:


VOTES FOR

%

VOTES AGAINST

%

VOTES TOTAL

% of ISC VOTED

VOTES WITHELD

Resolution 1

72,538,865

100.00

0

0.00

72,538,865

69.00%

0

Resolution 2

72,234,455

99.58

304,410

0.42

72,538,865

69.00%

0


Notes:

1.     All resolutions were passed.

2.     Votes "For" and "Against" are expressed as a percentage of votes received.

3.     A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" and Against" a resolution.

4.     Computershare acted as scrutineer of the poll on all resolutions.


The Company has instructed Numis and Baden Hill to procure subscribers for the shares not taken up in the Open Offer ("Rump Placing"). A further announcement will be made in due course if any further shares are to be issued in connection with the Rump Placing.

Applications have been made to the London Stock Exchange for up to 120,816,062 New Ordinary Shares to be admitted to trading on AIM. This comprises (1) 26,666,666 EIS Placing Shares which are expected to be admitted to trading at 8.00 a.m. on 1 August 2019; (2) 75,979,154 General Placing Shares and Open Offer Shares applied for which are expected to be admitted to trading at 8.00 a.m. on 2 August 2019; and (3) up to 18,170,242 New Ordinary Shares to the extent that these shares are placed with investors through the Rump Placing ("Rump Placing Shares"). The New Ordinary Shares will rank pari passu with the existing Ordinary Shares. A further announcement confirming the number of Rump Placing Shares will be published in due course.

This announcement should be read in conjunction with the full text of the circular dated 5 July 2019 (the "Circular"), published in connection with the Fundraising and capitalised terms used but not otherwise defined in this announcement bear the meanings ascribed to them in the Circular.

The person responsible for releasing this announcement on behalf of the Company is David Dorans, Chief Financial Officer, of the Company

 

About Mirriad

Mirriad is an established computer vision and AI-powered platform company, built on Academy Award-winning entertainment tech, with 30 patents and patents pending. Using sophisticated technologies, Mirriad connects people with brands, through seamless ad insertions in popular linear and digital content. Advertisers can now reach very large target audiences in a contextually relevant way without interrupting the viewing experience.

Research has consistently shown in-video advertising to be highly effective for the marketer and preferred by audiences on TV, online, and mobile.

Mirriad is headquartered in London, with offices in New York, Paris, Munich, Mumbai, and Shanghai. 

 

Enquiries

For further information please visit www.mirriad.com or contact:

 

Mirriad Advertising plc

Stephan Beringer, Chief Executive Officer

David Dorans, Chief Financial Officer              

Tel: +44 (0)207 884 2530

 

Numis Securities Limited (Nominated Adviser & Broker)

Nick Westlake                   

James Black          

Hugo Rubinstein

Tel: +44 (0) 207 260 1200

 

Financial Communications:

Charlotte Street Partners  

Andrew Wilson Tel: +44 (0) 7810 636995

Tom Gillingham Tel: +44 (0) 7741 659021

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ROMCKDDQKBKDNON

a d v e r t i s e m e n t